NewAmsterdam Pharma (NAMS) Current Assets (2021 - 2026)
NewAmsterdam Pharma (NAMS) posted Current Assets of $659.21 million for Q2 2026, down 14.4% from $769.85 million a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma's Current Assets came in at $675.7 million, down 21.7% from FY2024.
- Annual Current Assets shows a four-year compound annual growth rate of 76.5% (FY2021 to FY2025).
- In prior years, NewAmsterdam Pharma's Current Assets was $863.41 million in FY2024 (+149.0%), $346.79 million in FY2023 (-27.4%), $477.98 million in FY2022 (+586.0%) and $69.67 million in FY2021.
- Quarterly Current Assets has run from a low of $67.35 million in Q4 2021 to a high of $863.41 million in Q4 2024 over five years.
- On a year-over-year basis, Current Assets has declined in each of the last three quarters, with growth averaging 43.0% over the last seven quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2022, with growth of 578.9%; the weakest was Q4 2023, with a decline of 24.2%.
- According to Business Quant data, Current Assets for the three prior quarters was $658.04 million (Q1 2026), $675.7 million (Q4 2025) and $732.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | 659.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 659.21 Mn |
| Mar 31, 2026 | 658.04 Mn |
| Dec 31, 2025 | 675.70 Mn |
| Sep 30, 2025 | 732.33 Mn |
| Jun 30, 2025 | 769.85 Mn |
| Mar 31, 2025 | 817.30 Mn |
| Dec 31, 2024 | 863.41 Mn |
| Sep 30, 2024 | 437.87 Mn |
| Jun 30, 2024 | 445.35 Mn |
| Mar 31, 2024 | 487.82 Mn |
| Dec 31, 2023 | 346.79 Mn |
| Jun 30, 2023 | 423.88 Mn |
| Dec 31, 2022 | 457.21 Mn |
| Dec 31, 2021 | 67.35 Mn |
API Access
NewAmsterdam Pharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();